A study has found that there are similar safety profiles for -blockers and verapamil in patients with low-risk hypertrophic ...

The United Kingdom on Wednesday became the latest European country to restrict some form of health care access for transgender youth after indefinitely banning the sale and supply of puberty ...

The United Kingdom indefinitely extended a ban on puberty blockers for people younger than 18, barring medication prescriptions used to treat gender dysphoria, the government announced this week.

Long-term treatment with beta-blockers may not lower the risk of death or myocardial infarction (MI) in patients with MI, a preserved left ventricular ejection fraction (LVEF) of ≥50% and coronary ...

Interruption of beta-blocker treatment in patients with a history of myocardial infarction (MI) did not reduce risk of cardiovascular events or death, nor did it appear to improve quality of life ...

Copyright 2024 The Associated Press. All Rights Reserved. Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] LONDON (AP) — The British government ...

Puberty blockers are to be banned indefinitely after experts warned of an "unacceptable safety risk" to children. The Government has permanently banned the drugs that halt the sexual development ...

Puberty blockers prevent the onset of puberty in kids and are often administered as part of a medical gender transition regimen before other sex-suppressing hormone therapy and reconstructive ...

Puberty blockers are to be banned indefinitely in the UK after an expert review warned that the drugs posed an “unacceptable safety risk” to children. The Government said that an independent ...

Puberty blockers for under 18s with gender dysphoria with be banned indefinitely in the UK because of an “unacceptable safety risk”, the Department of Health and Social Care, led by Wes Streeting, has ...

An indefinite ban on the sale or supply of puberty blockers to under-18s is to come into effect in Northern Ireland. Puberty blockers work by suppressing the release of hormones and can be ...

Advances in cardiovascular pharmacology have significantly enhanced patient outcomes through a new wave of medications ranging from anticoagulants and antiplatelet agents to lipid-lowering drugs and ...